Spectroscopy startup Vibronix raises ~$15M Series B for commercialization push
What's the deal? Chinese optoelectronics startup Vibronix (Suzhou Weibang Zhendian Optoelectronics Technology) has closed a Series B round of nearly RMB 100 million, or roughly $15 million. Dalton VentureDealroom has a profile for this one. Try Dealroom → led the round, with IDG Capital participating.
What does it do? Founded in 2017, Vibronix develops molecular vibrational spectroscopy instruments, aiming to build high-end, domestically produced spectral analysis and imaging products. It runs three self-developed platforms: coherent Raman, transient absorption, and pulsed laser infrared.
What's the endgame? The company will use the funds to commercialize its products across industrial inspection, clinical applications, and AI for Science. It positions its instruments as replacements for imported solutions in life sciences, semiconductor and new-energy quality control, clinical diagnostics, and environmental science.
Vibronix says product sales have entered rapid growth, with deliveries to dozens of institutions and companies including Peking UniversityDealroom has a profile for this one. Try Dealroom →, the University of ViennaDealroom has a profile for this one. Try Dealroom →, Zhejiang UniversityDealroom has a profile for this one. Try Dealroom →, and the Shenzhen Institutes of Advanced TechnologyDealroom has a profile for this one. Try Dealroom →.
Prior to this round, the company had raised two earlier rounds from backers including FreeS FundDealroom has a profile for this one. Try Dealroom → and Naton CapitalDealroom has a profile for this one. Try Dealroom →.
In their words: "This round of financing will help Vibronix achieve a commercial leap across three directions: industrial inspection, clinical applications, and AI for Science," said chief executive officer Wang Pu. He added that the company aims to "build more competitive domestically made high-end scientific instruments." (translated from Chinese)
The signal: The round sits at the modest end of the funding spectrum, ranking in roughly the 47th percentile by size. But it reflects a broader push in China to localize high-end scientific instruments and to fuse spectral data with AI, moving domestic hardware from lab validation toward scaled commercialization.
Read more: elsewhere.news
Image credit: Suzhou Weibang Zhendian Optoelectronics Technology
